Xylitol Down-Regulates 1α,25-Dihydroxy Vitamin D3-induced Osteoclastogenesis via in Part the Inhibition of RANKL Expression in Osteoblasts
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Xylitol is a sugar alcohol with a variety of functions including bactericidal and anticariogenic effects. However,the cellular mechanisms underlying the role of xylitol in bone metabolism are not yet clarified. In our present study, we exploited the physiological role of xylitol on osteoclast differentiation in a co-culture system of osteoblastic and RAW 264.7 cells. Xylitol treatment of these co-cultures reduced the number of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells induced by 10 nM 1α,25(OH)2D3 in a dose‐dependent manner. A cell viability test revealed no marked cellular damage by up to 100 mM of xylitol. Exposure of osteoblastic cells to xylitol decreased RANKL,but not OPG, mRNA expression in the presence of 10-8M1α,25(OH)2D3 in a dose‐dependent manner. Furthermore,bone resorption activity, assessed on bone slices in the coculture system, was found to be dramatically decreased with increasing xylitol concentrations. RANKL and OPG proteins were assayed by ELISA and the soluble RANKL (sRANKL)concentration was decreased with an increased xylitol concentration. In contrast, OPG was unaltered by any xylitol concentration in this assay. These results indicate that xylitol inhibits 1α,25(OH)2D3-induced osteoclastogenesis by reducing the sRANKL/OPG expression ratio in osteoblastic cells.
Abstract
Xylitol is a sugar alcohol with a variety of functions including bactericidal and anticariogenic effects. However,the cellular mechanisms underlying the role of xylitol in bone metabolism are not yet clarified. In our present study, we exploited the physiological role of xylitol on osteoclast differentiation in a co-culture system of osteoblastic and RAW 264.7 cells. Xylitol treatment of these co-cultures reduced the number of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells induced by 10 nM 1α,25(OH)2D3 in a dose‐dependent manner. A cell viability test revealed no marked cellular damage by up to 100 mM of xylitol. Exposure of osteoblastic cells to xylitol decreased RANKL,but not OPG, mRNA expression in the presence of 10-8M1α,25(OH)2D3 in a dose‐dependent manner. Furthermore,bone resorption activity, assessed on bone slices in the coculture system, was found to be dramatically decreased with increasing xylitol concentrations. RANKL and OPG proteins were assayed by ELISA and the soluble RANKL (sRANKL)concentration was decreased with an increased xylitol concentration. In contrast, OPG was unaltered by any xylitol concentration in this assay. These results indicate that xylitol inhibits 1α,25(OH)2D3-induced osteoclastogenesis by reducing the sRANKL/OPG expression ratio in osteoblastic cells.
참고문헌 (26)
- Kitchens DH., "Xylitol in the prevention of oral diseases", Spec Care Dentist, 25(3), pp.140~144 (2005)
- Wunder D, "Action of agents on glucosyltransferases from Streptococcus mutans in solution and adsorbed to experimental pellicle", Arch Oral Biol, 44(3), pp.203~214 (1999)
- Svanberg M, "The effect of dietary xylitol on dentin formation in ovariectomized rats", Acta Odontol Scand, 52(2), pp.82~85 (1994)
- Svanberg M, "The effect of dietary xylitol on recalcifying and newly formed cortical long bone in rats", Calcif Tissue Int, 53(2), pp.135~138 (1993)
- Svanberg M, "Dietary xylitol prevents ovariectomy induced changes of bone inorganic fraction in rats", Bone Miner, 26(1), pp.81~88 (1994)
- Svanberg M, "Dietary xylitol retards bone resorption in rats", Miner Electrolyte Metab, 20(3), pp.153~157 (1994)
- Svanberg M, "Dietary xylitol retards the ovariectomy-induced increase of bone turnover in rats", Calcif Tissue Int, 60(5), pp.462~466 (1997)
- Burgess TL, "The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts", J Cell Biol, 145(3), pp.527~538 (1999)
- Fuller K, "TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts", J Exp Med, 188(5), pp.997~1001 (1998)
- Kong YY, "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis", Nature, 397(6717), pp.315~323 (1999)
- Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93(2), pp.165~176 (1998)
- 정현주, "Hypertonicity Down-regulates the 1a,25(OH)2 Vitamin D3-induced Osteoclastogenesis Via The Modulation of RANKL Expression in Osteoblast", International Journal of Oral Biology, 30(1), pp.23~30 (2005), 대한구강생물학회
- Eriksen EF, "Cellular mechanisms of bone remodeling", Rev Endocr Metab Disord, 11(4), pp.219~227 (2010)
- Aubin JE, "Advances in the osteoblast lineage", Biochem Cell Biol, 76(6), pp.899~910 (1998)
- Min-Ju Kim, "Altered Expression of RANKL", OPG after Alendronate Administration in the Developing Teeth of Postnatal Rats, 2011, pp.36(1), 37~42[DOI]
- Suda T, "Modulation of osteoclast differentiation by local factors", Bone, 17(2 Suppl), pp.87S~91S (1995)
- Takahashi N, "A new member of tumor necrosis factor ligand family, ODF", OPGL, RANKL, regulates osteoclast differentiation and function, pp.Biochem Biophys Res Commun, 1999[DOI]
- Tsukii K, "Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone", Biochem Biophys Res Commun, 246(2), pp.337~341 (1998)
- Jimi E, "Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function", J Immunol, 163(1), pp.434~442 (1999)
- Wong BR, "TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells", J Biol Chem, 272(40), pp.25190~25194 (1997)
- Udagawa N, "Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function", Endocrinology, 141(9), pp.3478~3484 (2000)
- Rani CS, "Dental cells express factors that regulate bone resorption", Mol Cell Biol Res Commun, 3(3), pp.145~152 (2000)
- Wise GE, "Enhancement of gene expression in rat dental follicle cells by parathyroid hormone-related protein", Arch Oral Biol, 45(10), pp.903~909 (2000)
- Kartsogiannis V, "Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues", Bone, 25(5), pp.525~534 (1999)
- Choi BK, "Effects of whole cell sonicates of Treponema lecithinolyticum on osteoclast differentiation", J Periodontol, 72(9), pp.1172~1177 (2001)
- Lee HA, "Bumetanide, the specific inhibitor of Na+-K+-2Cl- cotransport, inhibits 1alpha,25-dihydroxyvitamin D3-induced osteoclastogenesis in a mouse co-culture system", Exp Physiol, 88(5), pp.569~574 (2003)